These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8904249)

  • 1. [Degradation mechanism of cell cycle factors by the proteasome].
    Tsurumi C; Shimizu Y; Tanaka K
    Nihon Rinsho; 1996 Mar; 54(3):861-9. PubMed ID: 8904249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proteolysis and cell cycle regulation].
    Tsurumi C; Tanaka K
    Tanpakushitsu Kakusan Koso; 1996 Sep; 41(12 Suppl):1813-9. PubMed ID: 8890641
    [No Abstract]   [Full Text] [Related]  

  • 3. Ubiquitin/proteasome-mediated degradation of p19INK4d determines its periodic expression during the cell cycle.
    Thullberg M; Bartek J; Lukas J
    Oncogene; 2000 Jun; 19(24):2870-6. PubMed ID: 10851091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proteolytic enzyme and cell cycle regulation].
    Tanaka K
    Tanpakushitsu Kakusan Koso; 1993 Jul; 38(9):1520-6. PubMed ID: 8395069
    [No Abstract]   [Full Text] [Related]  

  • 5. Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation.
    Bernardi R; Liebermann DA; Hoffman B
    Oncogene; 2000 May; 19(20):2447-54. PubMed ID: 10828887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p27KIP1: androgen regulation and prognostic significance in prostate cancer.
    Loda M
    Adv Clin Path; 2000 Oct; 4(4):226-32. PubMed ID: 11436163
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of the ubiquitin proteasome pathway in human lens epithelial cells during the cell cycle.
    Liu Q; Shang F; Guo W; Hobbs M; Valverde P; Reddy V; Taylor A
    Exp Eye Res; 2004 Feb; 78(2):197-205. PubMed ID: 14729352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation.
    Borriello A; Pietra VD; Criscuolo M; Oliva A; Tonini GP; Iolascon A; Zappia V; Ragione FD
    Oncogene; 2000 Jan; 19(1):51-60. PubMed ID: 10644979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the proteasome in cellular protein degradation.
    Driscoll J
    Histol Histopathol; 1994 Jan; 9(1):197-202. PubMed ID: 8003815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanism of ubiquitin proteasome-regulated quality control in the endoplasmic reticulum].
    Tokunaga F
    Tanpakushitsu Kakusan Koso; 1999 May; 44(6):766-75. PubMed ID: 10341549
    [No Abstract]   [Full Text] [Related]  

  • 11. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation.
    Dai RM; Li CC
    Nat Cell Biol; 2001 Aug; 3(8):740-4. PubMed ID: 11483959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the mechanism responsible for TNF-mediated insulin resistance involve the proteasome?
    Pallarés-Trujillo J; Carbó N; López-Soriano FJ; Argilés JM
    Med Hypotheses; 2000 Apr; 54(4):565-9. PubMed ID: 10859639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ubiquitin-proteasome system and its role in ethanol-induced disorders.
    Donohue TM
    Addict Biol; 2002 Jan; 7(1):15-28. PubMed ID: 11900619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
    Ling YH; Liebes L; Jiang JD; Holland JF; Elliott PJ; Adams J; Muggia FM; Perez-Soler R
    Clin Cancer Res; 2003 Mar; 9(3):1145-54. PubMed ID: 12631620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The ubiquitin-ligating system: from the discovery to the present].
    Tanaka K
    Tanpakushitsu Kakusan Koso; 1999 May; 44(6):737-43. PubMed ID: 10341545
    [No Abstract]   [Full Text] [Related]  

  • 16. Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway.
    Honda K; Mihara H; Kato Y; Yamaguchi A; Tanaka H; Yasuda H; Furukawa K; Urano T
    Oncogene; 2000 Jun; 19(24):2812-9. PubMed ID: 10851084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deadly encounter: ubiquitin meets apoptosis.
    Jesenberger V; Jentsch S
    Nat Rev Mol Cell Biol; 2002 Feb; 3(2):112-21. PubMed ID: 11836513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early mitotic degradation of the homeoprotein HOXC10 is potentially linked to cell cycle progression.
    Gabellini D; Colaluca IN; Vodermaier HC; Biamonti G; Giacca M; Falaschi A; Riva S; Peverali FA
    EMBO J; 2003 Jul; 22(14):3715-24. PubMed ID: 12853486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells.
    Pasquini LA; Besio Moreno M; Adamo AM; Pasquini JM; Soto EF
    J Neurosci Res; 2000 Mar; 59(5):601-11. PubMed ID: 10686588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mos is degraded by the 26S proteasome in a ubiquitin-dependent fashion.
    Ishida N; Tanaka K; Tamura T; Nishizawa M; Okazaki K; Sagata N; Ichihara A
    FEBS Lett; 1993 Jun; 324(3):345-8. PubMed ID: 8405379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.